Advanced search
Publication Cover
Cancer Biology & Therapy Volume 19, 2018 - Issue 11
Submit an article Journal homepage
716
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

A rare case of multicentric castleman's disease transforms into multiple myeloma and its successful treatment

Dan YangDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
,
Xuan ZhouDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
,
Youcai ZhaoDepartment of Pathology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
,
Shibin CaoDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
,
Ailing SuDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
,
Xuezhong ZhangDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
,
Yanli XuDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
&
Xiuqun ZhangDepartment of Hematology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 949-952 | Received 08 Jan 2018, Accepted 19 Mar 2018, Published online: 30 Apr 2018

References

  • Castleman B, Towne VW. Case records of the Massachusetts General Hospital: Case No. 40231. N Eng J Med. 1954;250(23):1001–5. doi:10.1056/nejm195406102502308. PMID:13165944.
  • Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: Where are we now? Semin Diagn Pathol. 2016;33(5):294–306. doi:10.1053/j.semdp.2016.05.006. PMID:27296355.
  • Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman's disease: a systematic review of 404 published cases. Ann Surg. 2012;255(4):677–84. doi:10.1097/SLA.0b013e318249dcdc. PMID:22367441.
  • Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978;69(1):86–90. doi:10.1093/ajcp/69.1.86. PMID:619617.
  • Munshi N, Mehra M, van de Velde H, Desai A, Potluri R, Vermeulen J. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leukemia & lymphoma. 2015;56(5):1252–60. doi:10.3109/10428194.2014.953145.
  • Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014;123(19):2924–33. doi:10.1182/blood-2013-12-545087. PMID:24622327.
  • Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990;86(2):592–9. doi:10.1172/JCI114749. PMID:2384605.
  • Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, Tosato G, Janz S, Scheller J, Rose-John S. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood. 2012;119(22):5173–81. doi:10.1182/blood-2011-09-377705. PMID:22490805.
  • Rossi JF, Lu ZY, Jourdan M, Klein B. Interleukin-6 as a therapeutic target. Clin Cancer Res: an official journal of the American Association for Cancer Research. 2015;21(6):1248–57. doi:10.1158/1078-0432.CCR-14-2291. PMID:25589616.
  • Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, Raphael M. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol. 2002;69(2):119–26. doi:10.1002/ajh.10022. PMID:11835348.
  • Khan AA, Siraj F, Bhargava M, Aggarwal S. Successful treatment of multicentric Castleman's disease accompanying myeloma with bortezomib. Bmj Case Rep. 2012;2012. pii: bcr2012007646. doi:10.1136/bcr-2012-007646. PMID:23264156.
  • Chan KL, Lade S, Prince HM, Harrison SJ. Update and new approaches in the treatment of Castleman disease. J Blood Med. 2016;7:145–58. doi:10.2147/JBM.S60514. PMID:27536166.
  • Madan R, Chen JH, Trotman-Dickenson B, Jacobson F, Hunsaker A. The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management. Eur J Radiol. 2012;81(1):123–31. doi:10.1016/j.ejrad.2010.06.018. PMID:20643523.
  • Lee FC, Merchant SH. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide. Am J Hematol. 2003;73(1):48–53. doi:10.1002/ajh.10310. PMID:12701121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.